{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:53:08Z","timestamp":1789588388826,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"9-10","license":[{"start":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T00:00:00Z","timestamp":1696032000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T00:00:00Z","timestamp":1696032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2016R1A6A1A03011325"],"award-info":[{"award-number":["NRF-2016R1A6A1A03011325"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2022R1A2C1010771"],"award-info":[{"award-number":["2022R1A2C1010771"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Pharm. Res."],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s12272-023-01467-w","type":"journal-article","created":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T16:02:41Z","timestamp":1696089761000},"page":"795-807","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Exploring new histone deacetylase 6 inhibitors and their effects on reversing the \u03b1-tubulin deacetylation and cell morphology changes caused by methamphetamine"],"prefix":"10.1007","volume":"46","author":[{"given":"Sunil K.","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khan Hashim","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sooyeun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2268-8761","authenticated-orcid":false,"given":"Young Ho","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,30]]},"reference":[{"key":"1467_CR1","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1111\/ejn.14170","volume":"50","author":"EM Anderson","year":"2019","unstructured":"Anderson EM, Penrod RD, Barry SM, Hughes BW, Taniguchi M, Cowan CW (2019) It is a complex issue: emerging connections between epigenetic regulators in drug addiction. Eur J Neurosci 50:2477\u20132491. https:\/\/doi.org\/10.1111\/ejn.14170","journal-title":"Eur J Neurosci"},{"key":"1467_CR2","doi-asserted-by":"publisher","first-page":"10842","DOI":"10.1021\/ja102758v","volume":"132","author":"KV Butler","year":"2010","unstructured":"Butler KV, Kalin J, Brochier C, Vistoli G, Langley B, Kozikowski AP (2010) Rational design and simple chemistry yield a superior, neuroprotective HDAC6 inhibitor, tubastatin A. J Am Chem Soc 132:10842\u201310846. https:\/\/doi.org\/10.1021\/ja102758v","journal-title":"J Am Chem Soc"},{"key":"1467_CR3","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s00044-020-02665-7","volume":"30","author":"Y Cao","year":"2021","unstructured":"Cao Y, Luo C, Yang P, Li P, Wu C (2021) Indazole scaffold: a generalist for marketed and clinical drugs. Med Chem Res 30:501\u2013518. https:\/\/doi.org\/10.1007\/s00044-020-02665-7","journal-title":"Med Chem Res"},{"key":"1467_CR4","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1124\/mol.106.022301","volume":"70","author":"S Cassel","year":"2006","unstructured":"Cassel S, Carouge D, Gensburger C, Anglard P, Burgun C, Dietrich JB, Aunis D, Zwiller J (2006) Fluoxetine and cocaine induce the epigenetic factors MeCP2 and MBD1 in adult rat brain. Mol Pharmacol 70:487\u2013492. https:\/\/doi.org\/10.1124\/mol.106.022301","journal-title":"Mol Pharmacol"},{"key":"1467_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114582","volume":"240","author":"HY Chae","year":"2022","unstructured":"Chae HY, Park SY, Jha S, Gupta SK, Kim M, Ha E, Seo YH (2022) Design, synthesis, and biological evalution of bifunctional inhibitors against Hsp90-HDAC6 interplay. Eur J Med Chem 240:114582. https:\/\/doi.org\/10.1016\/j.ejmech.2022.114582","journal-title":"Eur J Med Chem"},{"key":"1467_CR6","doi-asserted-by":"publisher","first-page":"5884","DOI":"10.3390\/ijms15045884","volume":"15","author":"H Chauhan","year":"2014","unstructured":"Chauhan H, Killinger BA, Miller CV, Moszczynska A (2014) Single and binge methamphetamine administrations have different effects on the levels of dopamine D2 autoreceptor and dopamine transporter in rat striatum. Int J Mol Sci 15:5884\u20135906. https:\/\/doi.org\/10.3390\/ijms15045884","journal-title":"Int J Mol Sci"},{"key":"1467_CR7","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1007\/s12272-015-0571-1","volume":"38","author":"P Chun","year":"2015","unstructured":"Chun P (2015) Histone deacetylase inhibitors in hematological malignancies and solid tumors. Arch Pharmacal Res 38:933\u2013949. https:\/\/doi.org\/10.1007\/s12272-015-0571-1","journal-title":"Arch Pharmacal Res"},{"key":"1467_CR8","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s10147-011-0348-6","volume":"18","author":"T Doi","year":"2013","unstructured":"Doi T, Hamaguchi T, Shirao K, Chin K, Hatake K, Noguchi K, Otsuki T, Mehta A, Ohtsu A (2013) Evaluation of safety, pharmacokinetics, and efficacy of vorinostat, a histone deacetylase inhibitor, in the treatment of gastrointestinal (GI) cancer in a phase I clinical trial. Int J Clin Oncol 18:87\u201395. https:\/\/doi.org\/10.1007\/s10147-011-0348-6","journal-title":"Int J Clin Oncol"},{"key":"1467_CR9","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/s41419-018-0688-5","volume":"9","author":"SJ Fan","year":"2018","unstructured":"Fan SJ, Huang FI, Liou JP, Yang CR (2018) The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer\u2019s disease model. Cell Death Dis 9:655. https:\/\/doi.org\/10.1038\/s41419-018-0688-5","journal-title":"Cell Death Dis"},{"key":"1467_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00044-022-02987-8","volume":"32","author":"ZYL Faridoon","year":"2023","unstructured":"Faridoon ZYL, Zhang G, Li JJ (2023) Medicinal chemistry insights into non-hydroxamate HDAC6 selective inhibitors. Med Chem Res 32:1\u201314. https:\/\/doi.org\/10.1007\/s00044-022-02987-8","journal-title":"Med Chem Res"},{"key":"1467_CR11","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.toxlet.2015.02.011","volume":"234","author":"S Fernandes","year":"2015","unstructured":"Fernandes S, Salta S, Summavielle T (2015) Methamphetamine promotes \u03b1-tubulin deacetylation in endothelial cells: the protective role of acetyl-l-carnitine. Toxicol Lett 234:131\u2013138. https:\/\/doi.org\/10.1016\/j.toxlet.2015.02.011","journal-title":"Toxicol Lett"},{"key":"1467_CR12","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1080\/15592294.2015.1055441","volume":"10","author":"A Godino","year":"2015","unstructured":"Godino A, Jayanthi S, Cadet JL (2015) Epigenetic landscape of amphetamine and methamphetamine addiction in rodents. Epigenetics 10:574\u2013580. https:\/\/doi.org\/10.1080\/15592294.2015.1055441","journal-title":"Epigenetics"},{"key":"1467_CR13","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/npp.2017.159","volume":"43","author":"SM Groman","year":"2018","unstructured":"Groman SM, Rich KM, Smith NJ, Lee D, Taylor JR (2018) Chronic exposure to methamphetamine disrupts reinforcement-based decision making in rats. Neuropsychopharmacology 43:770\u2013780. https:\/\/doi.org\/10.1038\/npp.2017.159","journal-title":"Neuropsychopharmacology"},{"key":"1467_CR14","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/38664","volume":"389","author":"M Grunstein","year":"1997","unstructured":"Grunstein M (1997) Histone acetylation in chromatin structure and transcription. Nature 389:349\u2013352. https:\/\/doi.org\/10.1038\/38664","journal-title":"Nature"},{"key":"1467_CR15","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/nchembio.2134","volume":"12","author":"Y Hai","year":"2016","unstructured":"Hai Y, Christianson DW (2016) Histone deacetylase 6 structure and molecular basis of catalysis and inhibition. Nat Chem Biol 12:741\u2013747. https:\/\/doi.org\/10.1038\/nchembio.2134","journal-title":"Nat Chem Biol"},{"key":"1467_CR16","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1177\/0269881109348173","volume":"25","author":"L Host","year":"2011","unstructured":"Host L, Dietrich JB, Carouge D, Aunis D, Zwiller J (2011) Cocaine self-administration alters the expression of chromatin-remodelling proteins; modulation by histone deacetylase inhibition. J Psychopharmacol 25:222\u2013229. https:\/\/doi.org\/10.1177\/0269881109348173","journal-title":"J Psychopharmacol"},{"key":"1467_CR17","doi-asserted-by":"publisher","first-page":"6056","DOI":"10.1021\/acs.jmedchem.8b00393","volume":"61","author":"Y Huang","year":"2018","unstructured":"Huang Y, Dong G, Li H, Liu N, Zhang W, Sheng C (2018) Discovery of Janus Kinase 2 (JAK2) and Histone Deacetylase (HDAC) dual inhibitors as a novel strategy for the combinational treatment of leukemia and invasive fungal infections. J Med Chem 61:6056\u20136074. https:\/\/doi.org\/10.1021\/acs.jmedchem.8b00393","journal-title":"J Med Chem"},{"key":"1467_CR18","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/417455a","volume":"417","author":"C Hubbert","year":"2002","unstructured":"Hubbert C, Guardiola A, Shao R, Kawaguchi Y, Ito A, Nixon A, Yoshida M, Wang XF, Yao TP (2002) HDAC6 is a microtubule-associated deacetylase. Nature 417:455\u2013458. https:\/\/doi.org\/10.1038\/417455a","journal-title":"Nature"},{"key":"1467_CR19","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1007\/s12272-020-01284-5","volume":"43","author":"JS Hwang","year":"2020","unstructured":"Hwang JS, Cha EH, Park B, Ha E, Seo JH (2020) PBN inhibits a detrimental effect of methamphetamine on brain endothelial cells by alleviating the generation of reactive oxygen species. Arch Pharm Res 43:1347\u20131355. https:\/\/doi.org\/10.1007\/s12272-020-01284-5","journal-title":"Arch Pharm Res"},{"key":"1467_CR20","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/npp.2013.207","volume":"39","author":"J Jochems","year":"2014","unstructured":"Jochems J, Boulden J, Lee BG, Blendy JA, Jarpe M, Mazitschek R, Van Duzer JH, Jones S, Berton O (2014) Antidepressant-like properties of novel HDAC6-selective inhibitors with improved brain bioavailability. Neuropsychopharmacology 39:389\u2013400. https:\/\/doi.org\/10.1038\/npp.2013.207","journal-title":"Neuropsychopharmacology"},{"key":"1467_CR21","doi-asserted-by":"publisher","first-page":"145","DOI":"10.4062\/biomolther.2018.092","volume":"27","author":"Y Kang","year":"2019","unstructured":"Kang Y, Lee JH, Seo YH, Jang JH, Jeong CH, Lee S, Jeong GS, Park B (2019) Epicatechin prevents methamphetamine-induced neuronal cell death via inhibition of ER stress. Biomol Ther (seoul) 27:145\u2013151. https:\/\/doi.org\/10.4062\/biomolther.2018.092","journal-title":"Biomol Ther (seoul)"},{"key":"1467_CR22","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/s0092-8674(03)00939-5","volume":"115","author":"Y Kawaguchi","year":"2003","unstructured":"Kawaguchi Y, Kovacs JJ, Mclaurin A, Vance JM, Ito A, Yao TP (2003) The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress. Cell 115:727\u2013738. https:\/\/doi.org\/10.1016\/s0092-8674(03)00939-5","journal-title":"Cell"},{"key":"1467_CR23","doi-asserted-by":"publisher","first-page":"519","DOI":"10.4062\/biomolther.2020.041","volume":"28","author":"B Kim","year":"2020","unstructured":"Kim B, Jha S, Seo JH, Jeong CH, Lee S, Lee S, Seo YH, Park B (2020) MeBib suppressed methamphetamine self-administration response via inhibition of BDNF\/ERK\/CREB signal pathway in the hippocampus. Biomol Ther (seoul) 28:519\u2013526. https:\/\/doi.org\/10.4062\/biomolther.2020.041","journal-title":"Biomol Ther (seoul)"},{"key":"1467_CR24","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000029049","volume":"101","author":"JH Kim","year":"2022","unstructured":"Kim JH, Ali KH, Oh YJ, Seo YH (2022) Design, synthesis, and biological evaluation of histone deacetylase inhibitor with novel salicylamide zinc binding group. Medicine (baltimore) 101:e29049. https:\/\/doi.org\/10.1097\/md.0000000000029049","journal-title":"Medicine (baltimore)"},{"key":"1467_CR25","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/s0959-437x(99)80006-9","volume":"9","author":"T Kouzarides","year":"1999","unstructured":"Kouzarides T (1999) Histone acetylases and deacetylases in cell proliferation. Curr Opin Genet Dev 9:40\u201348. https:\/\/doi.org\/10.1016\/s0959-437x(99)80006-9","journal-title":"Curr Opin Genet Dev"},{"key":"1467_CR26","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1021\/acschemneuro.8b00600","volume":"10","author":"AP Kozikowski","year":"2019","unstructured":"Kozikowski AP, Shen S, Pardo M, Tavares MT, Szarics D, Benoy V, Zimprich CA, Kutil Z, Zhang G, Ba\u0159inka C, Robers MB, Van Den Bosch L, Eubanks JH, Jope RS (2019) Brain penetrable histone deacetylase 6 inhibitor SW-100 ameliorates memory and learning impairments in a mouse model of fragile X syndrome. ACS Chem Neurosci 10:1679\u20131695. https:\/\/doi.org\/10.1021\/acschemneuro.8b00600","journal-title":"ACS Chem Neurosci"},{"key":"1467_CR27","doi-asserted-by":"publisher","first-page":"7087","DOI":"10.1021\/acs.jmedchem.8b00151","volume":"61","author":"HY Lee","year":"2018","unstructured":"Lee HY, Fan SJ, Huang FI, Chao HY, Hsu KC, Lin TE, Yeh TK, Lai MJ, Li YH, Huang HL, Yang CR, Liou JP (2018) 5-aroylindoles act as selective histone deacetylase 6 inhibitors ameliorating Alzheimer\u2019s disease phenotypes. J Med Chem 61:7087\u20137102. https:\/\/doi.org\/10.1021\/acs.jmedchem.8b00151","journal-title":"J Med Chem"},{"key":"1467_CR28","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1007\/s12272-018-1045-z","volume":"41","author":"J Lim","year":"2018","unstructured":"Lim J, Song Y, Jang J-H, Jeong C-H, Lee S, Park B, Seo YH (2018) Aspirin-inspired acetyl-donating HDACs inhibitors. Arch Pharmacal Res 41:967\u2013976. https:\/\/doi.org\/10.1007\/s12272-018-1045-z","journal-title":"Arch Pharmacal Res"},{"key":"1467_CR29","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1002\/ddr.21979","volume":"83","author":"S Mal","year":"2022","unstructured":"Mal S, Malik U, Mahapatra M, Mishra A, Pal D, Paidesetty SK (2022) A review on synthetic strategy, molecular pharmacology of indazole derivatives, and their future perspective. Drug Dev Res 83:1469\u20131504. https:\/\/doi.org\/10.1002\/ddr.21979","journal-title":"Drug Dev Res"},{"key":"1467_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0034236","volume":"7","author":"TA Martin","year":"2012","unstructured":"Martin TA, Jayanthi S, Mccoy MT, Brannock C, Ladenheim B, Garrett T, Lehrmann E, Becker KG, Cadet JL (2012) Methamphetamine causes differential alterations in gene expression and patterns of histone acetylation\/hypoacetylation in the rat nucleus accumbens. PLoS ONE 7:e34236. https:\/\/doi.org\/10.1371\/journal.pone.0034236","journal-title":"PLoS ONE"},{"key":"1467_CR31","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/nchembio.2140","volume":"12","author":"Y Miyake","year":"2016","unstructured":"Miyake Y, Keusch JJ, Wang L, Saito M, Hess D, Wang X, Melancon BJ, Helquist P, Gut H, Matthias P (2016) Structural insights into HDAC6 tubulin deacetylation and its selective inhibition. Nat Chem Biol 12:748\u2013754. https:\/\/doi.org\/10.1038\/nchembio.2140","journal-title":"Nat Chem Biol"},{"key":"1467_CR32","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1002\/cmdc.202000149","volume":"15","author":"M Morgen","year":"2020","unstructured":"Morgen M, Steimbach RR, G\u00e9raldy M, Hellweg L, Sehr P, Ridinger J, Witt O, Oehme I, Herbst-Gervasoni CJ, Osko JD, Porter NJ, Christianson DW, Gunkel N, Miller AK (2020) Design and synthesis of dihydroxamic acids as HDAC6\/8\/10 inhibitors. ChemMedChem 15:1163\u20131174. https:\/\/doi.org\/10.1002\/cmdc.202000149","journal-title":"ChemMedChem"},{"key":"1467_CR33","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.neuro.2014.10.008","volume":"45","author":"O Omonijo","year":"2014","unstructured":"Omonijo O, Wongprayoon P, Ladenheim B, Mccoy MT, Govitrapong P, Jayanthi S, Cadet JL (2014) Differential effects of binge methamphetamine injections on the mRNA expression of histone deacetylases (HDACs) in the rat striatum. Neurotoxicology 45:178\u2013184. https:\/\/doi.org\/10.1016\/j.neuro.2014.10.008","journal-title":"Neurotoxicology"},{"key":"1467_CR34","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s12272-019-01126-z","volume":"42","author":"JW Park","year":"2019","unstructured":"Park JW, Han J-W (2019) Targeting epigenetics for cancer therapy. Arch Pharmacal Res 42:159\u2013170. https:\/\/doi.org\/10.1007\/s12272-019-01126-z","journal-title":"Arch Pharmacal Res"},{"key":"1467_CR35","doi-asserted-by":"publisher","first-page":"839","DOI":"10.2174\/1871520620999200818160350","volume":"21","author":"J Qin","year":"2021","unstructured":"Qin J, Cheng W, Duan YT, Yang H, Yao Y (2021) Indazole as a privileged scaffold: the derivatives and their therapeutic applications. Anticancer Agents Med Chem 21:839\u2013860. https:\/\/doi.org\/10.2174\/1871520620999200818160350","journal-title":"Anticancer Agents Med Chem"},{"key":"1467_CR36","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.canlet.2009.01.040","volume":"280","author":"J Schemies","year":"2009","unstructured":"Schemies J, Sippl W, Jung M (2009) Histone deacetylase inhibitors that target tubulin. Cancer Lett 280:222\u2013232. https:\/\/doi.org\/10.1016\/j.canlet.2009.01.040","journal-title":"Cancer Lett"},{"key":"1467_CR37","doi-asserted-by":"publisher","first-page":"6213","DOI":"10.3390\/ijms20246213","volume":"20","author":"C Sharma","year":"2019","unstructured":"Sharma C, Oh YJ, Park B, Lee S, Jeong CH, Lee S, Seo JH, Seo YH (2019) Development of thiazolidinedione-based HDAC6 inhibitors to overcome methamphetamine addiction. Int J Mol Sci 20:6213. https:\/\/doi.org\/10.3390\/ijms20246213","journal-title":"Int J Mol Sci"},{"key":"1467_CR38","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/cmdc.201500486","volume":"11","author":"S Shen","year":"2016","unstructured":"Shen S, Kozikowski AP (2016) Why hydroxamates may not be the best histone deacetylase inhibitors\u2014what some may have forgotten or would rather forget? ChemMedChem 11:15\u201321. https:\/\/doi.org\/10.1002\/cmdc.201500486","journal-title":"ChemMedChem"},{"key":"1467_CR39","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1080\/13543776.2019.1708901","volume":"30","author":"S Shen","year":"2020","unstructured":"Shen S, Kozikowski AP (2020) A patent review of histone deacetylase 6 inhibitors in neurodegenerative diseases (2014\u20132019). Expert Opin Ther Pat 30:121\u2013136. https:\/\/doi.org\/10.1080\/13543776.2019.1708901","journal-title":"Expert Opin Ther Pat"},{"key":"1467_CR40","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1021\/acsmedchemlett.9b00560","volume":"11","author":"S Shen","year":"2020","unstructured":"Shen S, Svoboda M, Zhang G, Cavasin MA, Motlova L, Mckinsey TA, Eubanks JH, Ba\u0159inka C, Kozikowski AP (2020) Structural and in vivo characterization of tubastatin A, a widely used histone deacetylase 6 inhibitor. ACS Med Chem Lett 11:706\u2013712. https:\/\/doi.org\/10.1021\/acsmedchemlett.9b00560","journal-title":"ACS Med Chem Lett"},{"key":"1467_CR41","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1021\/acscentsci.7b00274","volume":"3","author":"MG Strebl","year":"2017","unstructured":"Strebl MG, Campbell AJ, Zhao WN, Schroeder FA, Riley MM, Chindavong PS, Morin TM, Haggarty SJ, Wagner FF, Ritter T, Hooker JM (2017) HDAC6 brain mapping with [(18)F]bavarostat enabled by a Ru-mediated deoxyfluorination. ACS Cent Sci 3:1006\u20131014. https:\/\/doi.org\/10.1021\/acscentsci.7b00274","journal-title":"ACS Cent Sci"},{"key":"1467_CR42","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.2174\/092986705774454706","volume":"12","author":"T Suzuki","year":"2005","unstructured":"Suzuki T, Miyata N (2005) Non-hydroxamate histone deacetylase inhibitors. Curr Med Chem 12:2867\u20132880. https:\/\/doi.org\/10.2174\/092986705774454706","journal-title":"Curr Med Chem"},{"key":"1467_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112887","volume":"209","author":"MT Tavares","year":"2021","unstructured":"Tavares MT, Kozikowski AP, Shen S (2021) Mercaptoacetamide: a promising zinc-binding group for the discovery of selective histone deacetylase 6 inhibitors. Eur J Med Chem 209:112887. https:\/\/doi.org\/10.1016\/j.ejmech.2020.112887","journal-title":"Eur J Med Chem"},{"key":"1467_CR44","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s00280-007-0622-5","volume":"62","author":"KE Warren","year":"2008","unstructured":"Warren KE, Mccully C, Dvinge H, Tj\u00f8rnelund J, Sehested M, Lichenstein HS, Balis FM (2008) Plasma and cerebrospinal fluid pharmacokinetics of the histone deacetylase inhibitor, belinostat (PXD101), in non-human primates. Cancer Chemother Pharmacol 62:433\u2013437. https:\/\/doi.org\/10.1007\/s00280-007-0622-5","journal-title":"Cancer Chemother Pharmacol"},{"key":"1467_CR45","doi-asserted-by":"publisher","first-page":"12140","DOI":"10.1021\/acs.jmedchem.2c00853","volume":"65","author":"K Yue","year":"2022","unstructured":"Yue K, Sun S, Jia G, Qin M, Hou X, Chou CJ, Huang C, Li X (2022) First-in-class hydrazide-based HDAC6 selective inhibitor with potent oral anti-inflammatory activity by attenuating NLRP3 inflammasome activation. J Med Chem 65:12140\u201312162. https:\/\/doi.org\/10.1021\/acs.jmedchem.2c00853","journal-title":"J Med Chem"}],"container-title":["Archives of Pharmacal Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-023-01467-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12272-023-01467-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-023-01467-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T13:17:35Z","timestamp":1696857455000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12272-023-01467-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,30]]},"references-count":45,"journal-issue":{"issue":"9-10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["1467"],"URL":"https:\/\/doi.org\/10.1007\/s12272-023-01467-w","relation":{},"ISSN":["0253-6269","1976-3786"],"issn-type":[{"value":"0253-6269","type":"print"},{"value":"1976-3786","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,30]]},"assertion":[{"value":"2 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}